Cargando…
Evaluation and management approaches for scleroderma lung disease
Interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH) are leading causes of morbidity and mortality in systemic sclerosis (SSc). As symptoms are often under-reported in SSc, early screening of ILD and PAH is of paramount importance, and early treatment may be associated with bett...
Autores principales: | Schoenfeld, Sara R., Castelino, Flavia V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933653/ https://www.ncbi.nlm.nih.gov/pubmed/28621173 http://dx.doi.org/10.1177/1753465817713680 |
Ejemplares similares
-
Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management
por: Castelino, Flavia V, et al.
Publicado: (2010) -
Detection and Management of Interstitial Lung Diseases Associated With Connective Tissue Diseases
por: Castelino, Flavia V., et al.
Publicado: (2021) -
Scleroderma with Nodular Scleroderma
por: Srisuttiyakorn, Chutika, et al.
Publicado: (2016) -
Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United States
por: Bernstein, Elana J., et al.
Publicado: (2022) -
Scleroderma-related interstitial lung disease
por: Suliman, Sally, et al.
Publicado: (2017)